EC ever use among women of reproductive age: 0.4% (DHS 2006)
EC knowledge among women of reproductive age: 4.6% (DHS 2006)
Contraceptive Use: 23.1% (DHS 2006, ever use of any modern method among women of reproductive age)
Registered LNG-EC products:
- Escapelle* - Available directly from pharmacist without prescription (i.e. BTC)
- Postinor* - Available directly from pharmacist without prescription (i.e. BTC)
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Pharmacies
Age restrictions for accessing ECPs: No data available
Legal/regulatory documents in which EC is included: No data available
Other relevant information: In Azerbaijan, the lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is doctors, as of 2013. (USAID/DELIVER, Contraceptive Security Indicators, 2013)
In 2013, EC was not procured by the government (JSI/Deliver data).